Cited by 24Mobile Health and mHealth ApplicationsPhysical Activity and HealthDiabetes Management and Education

The Effects of a Lifestyle Intervention Supported by the InterWalk Smartphone App on Increasing Physical Activity Among Persons With Type 2 Diabetes: Parallel-Group, Randomized Trial

Open access
Thorsen, Ida Kær, Yang, Yanxiang, Valentiner, Laura Staun, Glümer, Charlotte, Karstoft, Kristian, Brønd, Jan Christian, Nielsen, Rasmus Oestergaard, Brøns, Charlotte +6 more·2022·JMIR mHealth and uHealth

Abstract

Background: Effective and sustainable implementation of physical activity (PA) in type 2 diabetes (T2D) health care has in general not been successful. Efficacious and contemporary approaches to support PA adherence and adoption are required. Objective: The primary objective of this study was to investigate the effectiveness of including an app-based (InterWalk) approach in municipality-based rehabilitation to increase moderate-and-vigorous PA (MVPA) across 52 weeks compared with standard care among individuals with T2D. Methods: The study was designed as a parallel-group, randomized trial with 52 weeks’ intervention and subsequent follow-up for effectiveness (52 weeks from baseline). Participants were recruited between January 2015 and December 2016 and randomly allocated (2:1) into 12 weeks of (1) standard care + InterWalk app–based interval walking training (IWT; IWT group; n=140), or (2) standard care + the standard exercise program (StC group; n=74). Following 12 weeks, the IWT group was encouraged to maintain InterWalk app–based IWT (3 times per week for 30-60 minutes) and the StC group was encouraged to maintain exercise without structured support. Moreover, half of the IWT group (IWTsupport group, n=54) received additional motivational support following the 12-week program until 52-week follow-up. The primary outcome was change in objectively measured MVPA time (minutes/day) from baseline to 52-week follow-up. Key secondary outcomes included changes in self-rated physical and mental health–related quality of life (HRQoL), physical fitness, weight, and waist circumference. Results: Participants had a mean age of 59.6 (SD 10.6) years and 128/214 (59.8%) were men. No changes in MVPA time were observed from baseline to 52-week follow-up in the StC and IWT groups (least squares means [95% CI] 0.6 [–4.6 to 5.8] and –0.2 [–3.8 to 3.3], respectively) and no differences were observed between the groups (mean difference [95% CI] –0.8 [–8.1 to 6.4] minutes/day; P=.82). Physical HRQoL increased by a mean of 4.3 (95% CI 1.8 to 6.9) 12-item Short-Form Health Survey (SF-12) points more in the IWT group compared with the StC group (Benjamini-Hochberg adjusted P=.007) and waist circumference apparently decreased a mean of –2.3 (95% CI –4.1 to –0.4) cm more in the IWT group compared with the StC group but with a Benjamini-Hochberg adjusted P=.06. No between-group differences were observed among the remaining key secondary outcomes. Conclusions: Among individuals with T2D referred to municipality-based lifestyle programs, randomization to InterWalk app–based IWT did not increase objectively measured MVPA time over 52 weeks compared with standard health care, although apparent benefits were observed for physical HRQoL. Trial Registration: ClinicalTrials.gov NCT02341690; https://clinicaltrials.gov/ct2/show/NCT02341690

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2196/30602

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Thorsen, I. K., Yang, Y., Valentiner, L. S., Glümer, C., Karstoft, K., Brønd, J. C., Nielsen, R. O., Brøns, C., Christensen, R., Nielsen, J. S., Vaag, A. A., Pedersen, B. K., Langberg, H., & Ried-Larsen, M.
Affiliations
  • Copenhagen University Hospital (DK)
  • Odense University Hospital (DK)
  • University of Copenhagen (DK)
  • Copenhagen Municipality (DK)
  • Bispebjerg Hospital (DK)
  • University of Southern Denmark (DK)
  • Aarhus University (DK)
  • Rigshospitalet (DK)
  • Steno Diabetes Center Copenhagen (DK)
Corresponding author
Thorsen, Ida Kær
Venue
JMIR mHealth and uHealth
Published
2022-09-28
Volume
10
Issue
9
Pages
e30602
ISSN
2291-5222 (ISSN-L)
OpenAlex
W4297458492
Cited by
24
References
49
Citations by year
2026: 7 · 2025: 6 · 2024: 10 · 2022: 1
FWCI
4.87
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JMIR mhealth and uhealth (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by)
Funders
  • Strategiske Forskningsråd (09–067009, 09 – 075724)
  • Parker Institute for Cancer Immunotherapy (OCAY-18-774-OFIL)
  • Steno Diabetes Center Copenhagen (SDCC 3.F CMP)
  • Vissing Fonden
  • National Research Foundation
  • Danmarks Grundforskningsfond (09-067009, DNRF55, 09-075724)
  • Novo Nordisk
  • Odense Universitetshospital
  • Augustinus Fonden
  • TrygFonden (20045, 125132, 101390)
  • Novo Nordisk Fonden (NNF17SA0030962-2)
  • Diabetesforeningen
  • Center for Strategic Research
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 2 diabetes, physical activity, mobile application, exercise adherence, motivational support, health-related quality of life, physical fitness, moderate-to-vigorous physical activity, exercise program comparison, digital health interventions, exercise enjoyment, exercise self-efficacy
MeSH terms
Diabetes Mellitus, Type 2, Female, Humans, Life Style, Male, Middle Aged, Quality of Life, Exercise, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review